Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Prev Med Public Health > Volume 50(4); 2017 > Article
Perspective
The Big Vitamin D Mistake
Dimitrios T. Papadimitriou1,2orcid
Journal of Preventive Medicine and Public Health 2017;50(4):278-281.
DOI: https://doi.org/10.3961/jpmph.16.111
Published online: May 10, 2017
  • 54,094 Views
  • 1,046 Download
  • 26 Crossref
  • 30 Scopus

1Third Department of Pediatrics, Division of Pediatric Endocrinology, Attikon University Hospital, University of Athens School of Medicine, Athens, Greece

2Pediatric-Adolescent Endocrinology and Diabetes, Athens Medical Center, Athens, Greece

Corresponding author: Dimitrios T. Papadimitriou, MD, PhD 58 Kifissias Ave., Athens 15125, Greece Tel: +30-210-363-8536, Fax: +30-210-610-6406 E-mail: info@pedoendo.gr
• Received: November 18, 2016   • Accepted: May 3, 2017

Copyright © 2017 The Korean Society for Preventive Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • Since 2006, type 1 diabetes in Finland has plateaued and then decreased after the authorities’ decision to fortify dietary milk products with cholecalciferol. The role of vitamin D in innate and adaptive immunity is critical. A statistical error in the estimation of the recommended dietary allowance (RDA) for vitamin D was recently discovered; in a correct analysis of the data used by the Institute of Medicine, it was found that 8895 IU/d was needed for 97.5% of individuals to achieve values ≥50 nmol/L. Another study confirmed that 6201 IU/d was needed to achieve 75 nmol/L and 9122 IU/d was needed to reach 100 nmol/L. The largest meta-analysis ever conducted of studies published between 1966 and 2013 showed that 25-hydroxyvitamin D levels <75 nmol/L may be too low for safety and associated with higher all-cause mortality, demolishing the previously presumed U-shape curve of mortality associated with vitamin D levels. Since all-disease mortality is reduced to 1.0 with serum vitamin D levels ≥100 nmol/L, we call public health authorities to consider designating as the RDA at least three-fourths of the levels proposed by the Endocrine Society Expert Committee as safe upper tolerable daily intake doses. This could lead to a recommendation of 1000 IU for children <1 year on enriched formula and 1500 IU for breastfed children older than 6 months, 3000 IU for children >1 year of age, and around 8000 IU for young adults and thereafter. Actions are urgently needed to protect the global population from vitamin D deficiency.
The incidence of type 1 diabetes (T1D) has been doubling every 20 years. In Finland, the recommendation for daily vitamin D supplementation was gradually reduced from 4000-5000 IU in 1964 to 400 IU in 1992. Concomitantly, T1D increased by 350% in those aged 1-4 years, 100% in those aged 5-9 years, and 50% in those aged 10-14 years [1]. However, since 2006, T1D has plateaued and decreased after an increase in serum 25-hydroxyvitamin D (25[OH]D) after the authorities’ decision to fortify all dietary milk products with cholecalciferol [2]. Moreover, the worldwide association of ultraviolet (UV)-B light and vitamin D status with T1D and multiple sclerosis is now more than evident.
Vitamin D and Immunomodulation
The role of vitamin D in innate and adaptive immunity is critical. It has been shown that the redirection of human autoreactive T-cells upon interaction with dendritic cells can be modulated by an analog of 1,25-dihydroxyvitamin D3 [3]. In a recent plenary session entitled “Cell Therapy in Type 1 Diabetes” that closed the 2016 meeting of the European Society for Paediatric Endocrinology in Paris, Bart O. Roep [3] announced the initiation of phase 1 clinical trials in humans in 2016 with the following protocol: dendritic cells will be isolated from the patient’s peripheral blood, cultured with calcitriol, and then re-injected in an abdominal intradermal position to ‘teach’ the rest of the immune cells not to attack β-cells anymore. In a large birth cohort study, T1D incidence was reduced by 78% with 2000 IU of cholecalciferol per day [4]. Moreover, T1D autoantibodies can be “negativated” with oral calcitriol [5]. Vitamin D levels >100 nmol/L (40 ng/mL with a conversion factor of ×2.5) improve insulin secretion [6] and prevent β-cell destruction by suppressing macrophage adhesion and migration through downregulation of endoplasmic reticulum stress and scavenger receptor-A1 [7].
The Statistical Error in the Estimation of the Recommended Dietary Allowance of Vitamin D
Veugelers and Ekwaru [8], in a correct reanalysis of the data used by the Institute of Medicine, proved that 8895 IU/d are needed for 97.5% of individuals to achieve values ≥50 nmol/L. Heaney et al. [9] confirmed that finding, reporting that 6201 IU/d were needed to achieve the Endocrine Society’s recommendation of 75 nmol/L and 9122 IU/day to reach 100 nmol/L.
What Serum Vitamin D Levels Should We Aim for?
Garland et al. [10] published the largest meta-analysis ever conducted of all studies published between January 1, 1966 and January 15, 2013 dealing with all-cause mortality related to serum 25(OH)D, showing that 25(OH)D levels <75 nmol/L may be too low for safety and associated with higher all-cause mortality, demolishing the U-shape curve of vitamin D levels and mortality that had been assumed until then.
Call to Public Health Authorities
Since all-disease (autoimmune diseases, metabolic syndrome, type 2 diabetes, cancer) mortality risk is reduced to 1.0 with serum vitamin D levels ≥100 nmol/L [10], we call all responsible public health authorities to consider designating as the recommended dietary allowance (i.e., the average daily level of intake sufficient to meet the nutrient requirements of nearly all healthy people, presuming minimal sun exposure) intake levels corresponding to those proposed by the Endocrine Society Expert Committee (2011) as safe upper tolerable daily intake doses for patients at risk for vitamin D deficiency (<50 nmol/L): 2000 IU for those <1 year of age, 4000 IU for those aged 1-18 years, and 10 000 IU for those aged >18 years.
Since 10 000 IU/d is needed to achieve 100 nmol/L [9], except for individuals with vitamin D hypersensitivity, and since there is no evidence of adverse effects associated with serum 25(OH)D levels <140 nmol/L, leaving a considerable margin of safety for efforts to raise the population-wide concentration to around 100 nmol/L, the doses we propose could be used to reach the level of 75 nmol/L or preferably 100 nmol/L. Of course, these recommended doses can be individualized based on dietary and sun exposure habits and the latitude of the country, and they can also be adjusted according to body mass index, age, and skin color, with obese, elderly, and dark-skinned people needing higher doses.
Explanation of the Pandemic of Vitamin D Deficiency
Only 20% of our vitamin D reserve is meant to come from the diet. The remaining 80% is expected to be produced in our skin from the UV-B of the sun. In contrast to the context of the recommendations of the 1960s of 4000 to 5000 IU/d to avoid rickets, our diet today is poor in wild fish (×10 richer in vitamin D), wild eggs, and fresh milk. Children are playing and people are working indoors all day long, and powerful sunprotective cosmetics are used to prevent melanoma. Even sunny countries such as Greece present a high prevalence of vitamin D deficiency, as the angle of the sun rays from autumn to spring do not result in sufficient vitamin D production with usual sun exposure.
Optimal Vitamin D Supplementation
With the target for vitamin D set at 100 nmol/L, the dose, frequency, and duration of supplementation will be important factors for healthy subjects committed to optimizing their nutritional status. Since in the case of vitamin D, serum levels depend on dietary intake (20%) and sun exposure (80%), a practical approach would be to recommend at least the three-fourths of the upper tolerable dose proposed by the Endocrine Society to be taken as a supplement all year long except for circumstances such as vacations in which one engages in sunbathing. This could translate to, for instance, 1000 IU for children <1 year on enriched formula and 1500 IU for those older than 6 months who are breastfed, 3000 IU for children >1 year of age, and up to 8000 IU for young adults and thereafter, with non-pediatric doses adapted to the body mass index with the target set to 100 nmol/L instead of 50 nmol/L. More importantly, according to the Endocrine Society’s clinical practice guidelines, doses up to 1000 IU/d for infants up to 6 months, 1500 IU/d for infants from 6 months to 1 year, 2500 IU/d for children aged 1-3 years, 3000 IU/d for children aged 4-8 years, and 4000 IU/d for everyone over 8 years can be given safely without medical supervision just to prevent vitamin D deficiency, while higher doses may be needed to correct hypovitaminosis D.
Importance of Vitamin D Supplementation
Such a strategy relies on adequate supplementation among pregnant and lactating women, and on timely supplementation of every newborn before seroconversion towards autoimmune targets occurs. The benefits for individuals’ general health status, apart from the obvious gains in skeletal health, cannot be fully foreseen, but may very well be surprisingly greater than expected given the impact of vitamin D deficiency on metabolic syndrome itself. Improvements in vitamin D status may help reduce the public health burden of metabolic syndrome and of potential subsequent health conditions, including type 2 diabetes and cardiovascular disease.
Unfortunately, medicine took a very long time to realize that vitamin D is not simply a vitamin that prevents rickets. For that purpose, 400-600 IU/d may be enough. However, we know today that vitamin D is a powerful nuclear receptor-activating hormone of critical importance, especially to the immune system. With the available data mentioned above, the proposed doses would probably suffice to maintain vitamin D levels around or over 75-100 nmol/L, with practically zero risk of toxicity. Undeniably, further studies are needed to clarify the optimal supplementation of vitamin D, although it is uncertain whether a universal recommended dietary allowance is feasible. Meanwhile, actions are urgently needed to protect the global population from the threats posed by vitamin D deficiency.

CONFLICT OF INTEREST

The author has no conflicts of interest associated with the material presented in this paper.

  • 1. Karvonen M, Pitkaniemi J, Tuomilehto J. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 1999;22(7):1066-1070ArticlePubMed
  • 2. Makinen M, Simell V, Mykkanen J, Ilonen J, Veijola R, Hyoty H, et al. An increase in serum 25-hydroxyvitamin D concentrations preceded a plateau in type 1 diabetes incidence in Finnish children. J Clin Endocrinol Metab 2014;99(11):E2353-E2356ArticlePubMedPMC
  • 3. van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C. Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes 2002;51(7):2119-2125ArticlePubMed
  • 4. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358(9292):1500-1503ArticlePubMed
  • 5. Papadimitriou DT, Marakaki C, Fretzayas A, Nicolaidou P, Papadimitriou A. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol. J Diabetes 2013;5(3):344-348ArticlePubMed
  • 6. Riek AE, Oh J, Darwech I, Moynihan CE, Bruchas RR, Bernal-Mizrachi C. 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J Steroid Biochem Mol Biol 2014;144 Pt A: 172-179ArticlePubMed
  • 7. Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, et al. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency: a double-blind, randomized, placebo-controlled trial. Metabolism 2014;63(9):1115-1124ArticlePubMed
  • 8. Veugelers PJ, Ekwaru JP. A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients 2014;6(10):4472-4475ArticlePubMedPMC
  • 9. Heaney R, Garland C, Baggerly C, French C, Gorham E. Letter to Veugelers, P.J. and Ekwaru, J.P., A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients 2014, 6, 4472-4475; doi:10.3390/nu6104472. Nutrients 2015;7(3):1688-1690ArticlePubMedPMC
  • 10. Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, et al. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health 2014;104(8):e43-e50Article

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Prevalence and determinants of insufficient vitamin D status in young Canadian Inuit children from Nunavik
      Huguette Turgeon O’Brien, Doris Gagné, Rosanne Blanchet, Carole Vézina
      Nutrition and Health.2024;[Epub]     CrossRef
    • Common Nutritional Shortcomings in Vegetarians and Vegans
      Joshua Gibbs, Francesco P. Cappuccio
      Dietetics.2024; 3(2): 114.     CrossRef
    • Serum vitamin D and cardiometabolic risk factors in the UK population
      Linia Patel, Carlo La Vecchia, Gianfranco Alicandro
      Journal of Human Nutrition and Dietetics.2023; 36(3): 1019.     CrossRef
    • A Narrative Review on the Potential Role of Vitamin D3 in the Prevention, Protection, and Disease Mitigation of Acute and Long COVID-19
      Meis Moukayed
      Current Nutrition Reports.2023; 12(2): 215.     CrossRef
    • Mushrooms as Functional Foods for Ménière’s Disease
      Victoria Bell, Tito Horácio Fernandes
      Applied Sciences.2023; 13(22): 12348.     CrossRef
    • Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data
      Rodis D. Paparodis, Dimitra Bantouna, Evangelos Karvounis, Ioannis Zoupas, Sarantis Livadas, Nicholas Angelopoulos, Shahnawaz Imam, Dimitrios T. Papadimitriou, Juan C. Jaume
      Nutrients.2023; 16(1): 111.     CrossRef
    • Role of vitamin D deficiency and comorbidities in COVID-19
      Gabriela Gama Freire Alberca, Ricardo Wesley Alberca
      World Journal of Virology.2022; 11(1): 85.     CrossRef
    • Rifampicin for COVID-19
      George D Panayiotakopoulos, Dimitrios T Papadimitriou
      World Journal of Virology.2022; 11(2): 90.     CrossRef
    • Perspective: Darwinian Applications to Nutrition—The Value of Evolutionary Insights to Teachers and Students
      Eirik Garnås
      Advances in Nutrition.2022; 13(5): 1431.     CrossRef
    • Latent toxoplasmosis and vitamin D concentration in humans: three observational studies
      Sarka Kankova, Marie Bicikova, Ludmila Macova, Jana Hlavacova, Katerina Sykorova, Dobroslava Jandova, Jaroslav Flegr
      Folia Parasitologica.2021;[Epub]     CrossRef
    • The role of vitamin D in reducing SARS-CoV-2 infection: An update
      Mohammad Shah Alam, Daniel M. Czajkowsky, Md. Aminul Islam, Md. Ataur Rahman
      International Immunopharmacology.2021; 97: 107686.     CrossRef
    • Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach
      Dimitrios T Papadimitriou, Alexandros K Vassaras, Michael F Holick
      World Journal of Virology.2021; 10(3): 111.     CrossRef
    • Serum iPTH range in a reference population: From an integrated approach to vitamin D prevalence impact evaluation
      Marilena Minieri, Bruno Daniele Leoni, Lorenza Bellincampi, Daniela Bajo, Alessia Agnoli, Anna Maria De Angelis, Massimo Pieri, Francesco Equitani, Vincenzo Rossi, Filippa Valente, Stefano Pignalosa, Alessandro Terrinoni, Sergio Bernardini
      Clinica Chimica Acta.2021; 521: 1.     CrossRef
    • The Impact of SARS-CoV-2 Pandemic on the New Cases of T1DM in Children. A Single-Centre Cohort Study
      Anca Andreea Boboc, Carmen Nicoleta Novac, Maria Teodora Ilie, Mara Ioana Ieșanu, Felicia Galoș, Mihaela Bălgrădean, Elena Camelia Berghea, Marcela Daniela Ionescu
      Journal of Personalized Medicine.2021; 11(6): 551.     CrossRef
    • COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis
      Lorenz Borsche, Bernd Glauner, Julian von Mendel
      Nutrients.2021; 13(10): 3596.     CrossRef
    • Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice
      Ignazio Castagliuolo, Melania Scarpa, Paola Brun, Giulia Bernabe, Valeria Sagheddu, Marina Elli, Walter Fiore, Valerio De Vitis, Simone Guglielmetti
      Annals of Microbiology.2021;[Epub]     CrossRef
    • Association between Vitamin D Supplementation and Mental Health in Healthy Adults: A Systematic Review
      Dominika Guzek, Aleksandra Kołota, Katarzyna Lachowicz, Dominika Skolmowska, Małgorzata Stachoń, Dominika Głąbska
      Journal of Clinical Medicine.2021; 10(21): 5156.     CrossRef
    • Relationship between plasma levels of 25-hydroxyvitamin D and arterial stiffness in elderly Chinese with non-dipper hypertension
      Jian-Wei Gu, Ju-Hua Liu, Hui-Neng Xiao, Yun-Feng Yang, Wen-Ju Dong, Quan-Bo Zhang, Li Liu, Cheng-Shi He, Bi-Hua Wu
      Medicine.2020; 99(7): e19200.     CrossRef
    • Sunlight and health: shifting the focus from vitamin D3 to photobiomodulation by red and near-infrared light
      Vladimir Heiskanen, Morgan Pfiffner, Timo Partonen
      Ageing Research Reviews.2020; 61: 101089.     CrossRef
    • Effects of circulating vitamin D concentrations on emotion, behavior and attention: A cross-sectional study in preschool children with follow-up behavior experiments in juvenile mice
      Xirui Wang, Xianting Jiao, Mingqing Xu, Bin Wang, Juan Li, Fan Yang, Lishan Zhang, Lei Xu, Xiaodan Yu
      Journal of Affective Disorders.2020; 275: 290.     CrossRef
    • The role of vitamin D in seasonal acute respiratory viral infections and COVID-19
      E. A. Pigarova, A. A. Povalyaeva, L. K. Dzeranova, L. Y. Rozhinskaya, N. G. Mokrysheva
      Terapevticheskii arkhiv.2020; 92(11): 98.     CrossRef
    • Pediatric natural health products recommended by chiropractic and naturopathic doctors in Canada
      Antony Joseph Porcino, Leslie Solomonian, Stephen Zylich, Chantal Doucet, Brian Gluvic, Sunita Vohra
      Complementary Therapies in Medicine.2019; 43: 196.     CrossRef
    • Skin fairness is a better predictor for impaired physical and mental health than hair redness
      Jaroslav Flegr, Kateřina Sýkorová
      Scientific Reports.2019;[Epub]     CrossRef
    • Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome
      Osama Adnan Kensara
      Journal of Clinical & Translational Endocrinology.2018; 12: 20.     CrossRef
    • Role of nutritional vitamin D in osteoporosis treatment
      Yi-Chou Hou, Chia-Chao Wu, Min-Tser Liao, Jia-Fwu Shyu, Chi-Feng Hung, Tzung-Hai Yen, Chien-Lin Lu, Kuo-Cheng Lu
      Clinica Chimica Acta.2018; 484: 179.     CrossRef
    • Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl
      Christina Bothou, Alexis Alexopoulos, Eleni Dermitzaki, Kleanthis Kleanthous, Anastasios Papadimitriou, George Mastorakos, Dimitrios T. Papadimitriou
      Case Reports in Pediatrics.2018; 2018: 1.     CrossRef


    JPMPH : Journal of Preventive Medicine and Public Health